271 related articles for article (PubMed ID: 24117238)
41. Exploring Mechanisms of Communication Switching in the Hsp90-Cdc37 Regulatory Complexes with Client Kinases through Allosteric Coupling of Phosphorylation Sites: Perturbation-Based Modeling and Hierarchical Community Analysis of Residue Interaction Networks.
Stetz G; Astl L; Verkhivker GM
J Chem Theory Comput; 2020 Jul; 16(7):4706-4725. PubMed ID: 32492340
[TBL] [Abstract][Full Text] [Related]
42. The Therapeutic Potential of Targeting Hsp90-Cdc37 Interactions in Several Diseases.
Zhang X; Li S; Li Z; Cheng L; Liu Z; Wang C
Curr Drug Targets; 2022; 23(10):1023-1038. PubMed ID: 35400341
[TBL] [Abstract][Full Text] [Related]
43. The CDC37-HSP90 chaperone complex co-translationally degrades the nascent kinase-dead mutant of HIPK2.
Müller JP; Klempnauer KH
FEBS Lett; 2021 Jun; 595(11):1559-1568. PubMed ID: 33786814
[TBL] [Abstract][Full Text] [Related]
44. The Hsp90 chaperone machinery: conformational dynamics and regulation by co-chaperones.
Li J; Soroka J; Buchner J
Biochim Biophys Acta; 2012 Mar; 1823(3):624-35. PubMed ID: 21951723
[TBL] [Abstract][Full Text] [Related]
45. Swe1Wee1-dependent tyrosine phosphorylation of Hsp90 regulates distinct facets of chaperone function.
Mollapour M; Tsutsumi S; Donnelly AC; Beebe K; Tokita MJ; Lee MJ; Lee S; Morra G; Bourboulia D; Scroggins BT; Colombo G; Blagg BS; Panaretou B; Stetler-Stevenson WG; Trepel JB; Piper PW; Prodromou C; Pearl LH; Neckers L
Mol Cell; 2010 Feb; 37(3):333-43. PubMed ID: 20159553
[TBL] [Abstract][Full Text] [Related]
46. Middle domain of human Hsp90 isoforms differentially binds Aha1 in human cells and alters Hsp90 activity in yeast.
Synoradzki K; Bieganowski P
Biochim Biophys Acta; 2015 Feb; 1853(2):445-52. PubMed ID: 25486457
[TBL] [Abstract][Full Text] [Related]
47. A client-binding site of Cdc37.
Terasawa K; Minami Y
FEBS J; 2005 Sep; 272(18):4684-90. PubMed ID: 16156789
[TBL] [Abstract][Full Text] [Related]
48. Cdc37-Hsp90 complexes are responsive to nucleotide-induced conformational changes and binding of further cofactors.
Gaiser AM; Kretzschmar A; Richter K
J Biol Chem; 2010 Dec; 285(52):40921-32. PubMed ID: 20880838
[TBL] [Abstract][Full Text] [Related]
49. Hsp90-dependent activation of protein kinases is regulated by chaperone-targeted dephosphorylation of Cdc37.
Vaughan CK; Mollapour M; Smith JR; Truman A; Hu B; Good VM; Panaretou B; Neckers L; Clarke PA; Workman P; Piper PW; Prodromou C; Pearl LH
Mol Cell; 2008 Sep; 31(6):886-95. PubMed ID: 18922470
[TBL] [Abstract][Full Text] [Related]
50. Post-translational modifications of Hsp90 and their contributions to chaperone regulation.
Mollapour M; Neckers L
Biochim Biophys Acta; 2012 Mar; 1823(3):648-55. PubMed ID: 21856339
[TBL] [Abstract][Full Text] [Related]
51. Hsp90/p50cdc37 is required for mixed-lineage kinase (MLK) 3 signaling.
Zhang H; Wu W; Du Y; Santos SJ; Conrad SE; Watson JT; Grammatikakis N; Gallo KA
J Biol Chem; 2004 May; 279(19):19457-63. PubMed ID: 15001580
[TBL] [Abstract][Full Text] [Related]
52. ATP-Driven Nonequilibrium Activation of Kinase Clients by the Molecular Chaperone Hsp90.
Xu H
Biophys J; 2020 Oct; 119(8):1538-1549. PubMed ID: 33038305
[TBL] [Abstract][Full Text] [Related]
53. Phosphorylation of serine 13 is required for the proper function of the Hsp90 co-chaperone, Cdc37.
Shao J; Prince T; Hartson SD; Matts RL
J Biol Chem; 2003 Oct; 278(40):38117-20. PubMed ID: 12930845
[TBL] [Abstract][Full Text] [Related]
54. Chaperoning checkpoint kinase 1 (Chk1), an Hsp90 client, with purified chaperones.
Arlander SJ; Felts SJ; Wagner JM; Stensgard B; Toft DO; Karnitz LM
J Biol Chem; 2006 Feb; 281(5):2989-98. PubMed ID: 16330544
[TBL] [Abstract][Full Text] [Related]
55. A central role for the Hsp90.Cdc37 molecular chaperone module in interleukin-1 receptor-associated-kinase-dependent signaling by toll-like receptors.
De Nardo D; Masendycz P; Ho S; Cross M; Fleetwood AJ; Reynolds EC; Hamilton JA; Scholz GM
J Biol Chem; 2005 Mar; 280(11):9813-22. PubMed ID: 15647277
[TBL] [Abstract][Full Text] [Related]
56. The therapeutic target Hsp90 and cancer hallmarks.
Miyata Y; Nakamoto H; Neckers L
Curr Pharm Des; 2013; 19(3):347-65. PubMed ID: 22920906
[TBL] [Abstract][Full Text] [Related]
57. The Mechanism of Hsp90 regulation by the protein kinase-specific cochaperone p50(cdc37).
Roe SM; Ali MM; Meyer P; Vaughan CK; Panaretou B; Piper PW; Prodromou C; Pearl LH
Cell; 2004 Jan; 116(1):87-98. PubMed ID: 14718169
[TBL] [Abstract][Full Text] [Related]
58. Specific association of a set of molecular chaperones including HSP90 and Cdc37 with MOK, a member of the mitogen-activated protein kinase superfamily.
Miyata Y; Ikawa Y; Shibuya M; Nishida E
J Biol Chem; 2001 Jun; 276(24):21841-8. PubMed ID: 11278794
[TBL] [Abstract][Full Text] [Related]
59. A specialized Hsp90 co-chaperone network regulates steroid hormone receptor response to ligand.
Backe SJ; Sager RA; Regan BR; Sit J; Major LA; Bratslavsky G; Woodford MR; Bourboulia D; Mollapour M
Cell Rep; 2022 Jul; 40(2):111039. PubMed ID: 35830801
[TBL] [Abstract][Full Text] [Related]
60. In silico design of small peptide-based Hsp90 inhibitor: a novel anticancer agent.
Gupta UK; Mahanta S; Paul S
Med Hypotheses; 2013 Nov; 81(5):853-61. PubMed ID: 24018284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
